Skip to main content
Synbiotic SE logo

Synbiotic SE — Investor Relations & Filings

Ticker · SBX ISIN · DE000A3E5A59 LEI · 48510041U2G1IWA3R418 F Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2023-08-29 Director's Dealing
Country DE Germany
Listing F SBX

About Synbiotic SE

https://www.synbiotic.com/

Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.

Recent filings

Filing Released Lang Actions
SynBiotic SE: MARKTFLAGGE GmbH, Gewahrung von 12.000 Bezugsrechten im Rahmen der Begebung einer Wandelschuldverschreibung
Director's Dealing Classification · 99% confidence The document is titled 'Directors’ Dealings' and contains a section explicitly labeled 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). It details a transaction involving 'MARKTFLAGGE GmbH' which is closely related to 'Sebastian Stietzel', a member of the Supervisory Board ('Aufsichtsrat'). This directly corresponds to the definition of Director's Dealing reports.
2023-08-29 German
SynBiotic SE: t-grove GmbH, Gewahrung von 12.000 Bezugsrechten im Rahmen einer Bezugsrechtskapitalerhohung
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). It details a transaction involving a member of the Supervisory Board ('Aufsichtsrat') and an associated entity (t-grove GmbH). This directly corresponds to the definition of Director's Dealing.
2023-08-29 German
SynBiotic SE: t-grove GmbH, Gewahrung von 12.000 Bezugsrechten im Rahmen der Begebung einer Wandelschuldverschreibung
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and explicitly states it is a 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). It details a transaction involving a director (Thomas Hanke, Aufsichtsrat) and an associated entity (t-grove GmbH). This directly matches the definition for Director's Dealing.
2023-08-29 German
SynBiotic SE: Thomas Hanke, Gewahrung von 8.500 Bezugsrechten im Rahmen der Begebung einer Wandelschuldverschreibung
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). This directly corresponds to the definition of Director's Dealing reports. The specific code for this type of filing is DIRS.
2023-08-29 German
SynBiotic SE: Thomas Hanke, Gewahrung von 8.500 Bezugsrechten im Rahmen einer Bezugsrechtskapitalerhohung
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and explicitly states it is a 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities). It details a transaction (granting of subscription rights) involving a member of the Supervisory Board ('Aufsichtsrat'), Thomas Hanke. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2023-08-29 German
Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO
M&A Activity Classification · 100% confidence The document is a news release dated August 21, 2023, disseminated via EQS-News. It announces significant corporate actions: an investment by Frank Otto, the acquisition of a majority stake in CannaCare Health, and the appointment of Daniel Kruse as CEO. The keywords 'Financing/Takeover' and the content detailing investment, acquisition, and management changes strongly suggest a corporate event announcement. Since it is not a full annual report (10-K), a quarterly report (IR), a formal earnings release (ER), or a specific regulatory filing like a Director's Dealing (DIRS) or Proxy Statement (PSI), it falls best under the category of general corporate news or a significant event announcement. Given the options, this type of material—announcing financing, M&A activity, and management changes—is often classified as a Regulatory Filing (RNS) if it doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP). However, the core content is about an acquisition and financing, which are covered by TAR and CAP. Since it explicitly mentions 'Takeover' in the keywords and details an acquisition and investment, 'TAR' (M&A Activity) or 'CAP' (Capital/Financing Update) are strong candidates. Because it combines both acquisition (M&A) and investment (Financing), and the announcement format is typical of a broad regulatory disclosure, RNS is the safest fallback, but TAR covers the acquisition aspect well. Given the explicit mention of 'Takeover' in the keywords and the acquisition of a majority stake, TAR is the most specific fit for the primary event, although it also contains financing elements. Since it's a broad announcement covering multiple strategic moves (M&A, Financing, Management Change), and RNS is the general regulatory announcement category, I will lean towards RNS as the most encompassing classification for this type of press release unless the M&A or Financing aspect is overwhelmingly dominant. The document structure is that of a standard press release announcing strategic moves, which often defaults to RNS if not a specific financial report. I will classify it as RNS as it is a general corporate news announcement disseminated via a regulatory news service (EQS-News).
2023-08-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.